Capsular tension ring decreases PCO after surgery

Article

Implantation of a capsular tension ring effectively reduces the percentage area of posterior capsular opacification (PCO) and the Nd:YAG laser capsulotomy rate in patients with highly myopic eyes, according to researchers in Albania and Turkey.

Implantation of a capsular tension ring effectively reduces the percentage area of posterior capsular opacification (PCO) and the Nd:YAG laser capsulotomy rate in patients with highly myopic eyes, according to researchers in Albania and Turkey.

The researchers conducted a prospective, single-surgeon, standardized-surgical-procedure fellow-eye comparison trial in which 34 highly myopic patients had phacoemulsification surgery.

All of the patients received an acrylic intraocular lens (IOL) and a capsular tension ring in one eye; the other eye served as a control by receiving the IOL only. The researchers documented PCO within the capsulorhexis overlap using standardized digital retroillumination images at least 2 years postoperatively and scored the percentage area of PCO. The researchers also determined the PCO score and the incidence of Nd: YAG capsulotomy of the eyes.

The researchers found that the PCO score of the eyes with a capsular tension ring was significantly lower (5.9 ± 4.3) than that of the controls (22.3 ± 12.2) (P P = 0.025).

"Even though [capsular tension ring] implantation is not routine in cataract surgery, its implantation should be considered in high myopic patients who have zonular instability and retinal pathologies posing risk for Nd:YAG capsulotomy," the researchers wrote.

Read the entire study in the Indian Journal of Ophthalmology.

Recent Videos
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
© 2025 MJH Life Sciences

All rights reserved.